HLA variation and disease

Calliope A. Dendrou, Jan Petersen, Jamie Rossjohn, Lars Fugger

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Fifty years since the first description of an association between HLA and human disease, HLA molecules have proven to be central to physiology, protective immunity and deleterious, disease-causing autoimmune reactivity. Technological advances have enabled pivotal progress in the determination of the molecular mechanisms that underpin the association between HLA genetics and functional outcome. Here, we review our current understanding of HLA molecules as the fundamental platform for immune surveillance and responsiveness in health and disease. We evaluate the scope for personalized antigen-specific disease prevention, whereby harnessing HLA-ligand interactions for clinical benefit is becoming a realistic prospect.

Original languageEnglish
Pages (from-to)325-339
Number of pages15
JournalNature Reviews Immunology
Volume18
Issue number5
DOIs
Publication statusPublished - 2 Jan 2018

Keywords

  • autoimmunity
  • genetic predisposition to disease
  • MHC

Cite this

Dendrou, Calliope A. ; Petersen, Jan ; Rossjohn, Jamie ; Fugger, Lars. / HLA variation and disease. In: Nature Reviews Immunology. 2018 ; Vol. 18, No. 5. pp. 325-339.
@article{c657a13c5d2d4f9bb33fce6ece98164c,
title = "HLA variation and disease",
abstract = "Fifty years since the first description of an association between HLA and human disease, HLA molecules have proven to be central to physiology, protective immunity and deleterious, disease-causing autoimmune reactivity. Technological advances have enabled pivotal progress in the determination of the molecular mechanisms that underpin the association between HLA genetics and functional outcome. Here, we review our current understanding of HLA molecules as the fundamental platform for immune surveillance and responsiveness in health and disease. We evaluate the scope for personalized antigen-specific disease prevention, whereby harnessing HLA-ligand interactions for clinical benefit is becoming a realistic prospect.",
keywords = "autoimmunity, genetic predisposition to disease, MHC",
author = "Dendrou, {Calliope A.} and Jan Petersen and Jamie Rossjohn and Lars Fugger",
year = "2018",
month = "1",
day = "2",
doi = "10.1038/nri.2017.143",
language = "English",
volume = "18",
pages = "325--339",
journal = "Nature Reviews Immunology",
issn = "1474-1733",
publisher = "Nature Publishing Group",
number = "5",

}

HLA variation and disease. / Dendrou, Calliope A.; Petersen, Jan; Rossjohn, Jamie; Fugger, Lars.

In: Nature Reviews Immunology, Vol. 18, No. 5, 02.01.2018, p. 325-339.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - HLA variation and disease

AU - Dendrou, Calliope A.

AU - Petersen, Jan

AU - Rossjohn, Jamie

AU - Fugger, Lars

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Fifty years since the first description of an association between HLA and human disease, HLA molecules have proven to be central to physiology, protective immunity and deleterious, disease-causing autoimmune reactivity. Technological advances have enabled pivotal progress in the determination of the molecular mechanisms that underpin the association between HLA genetics and functional outcome. Here, we review our current understanding of HLA molecules as the fundamental platform for immune surveillance and responsiveness in health and disease. We evaluate the scope for personalized antigen-specific disease prevention, whereby harnessing HLA-ligand interactions for clinical benefit is becoming a realistic prospect.

AB - Fifty years since the first description of an association between HLA and human disease, HLA molecules have proven to be central to physiology, protective immunity and deleterious, disease-causing autoimmune reactivity. Technological advances have enabled pivotal progress in the determination of the molecular mechanisms that underpin the association between HLA genetics and functional outcome. Here, we review our current understanding of HLA molecules as the fundamental platform for immune surveillance and responsiveness in health and disease. We evaluate the scope for personalized antigen-specific disease prevention, whereby harnessing HLA-ligand interactions for clinical benefit is becoming a realistic prospect.

KW - autoimmunity

KW - genetic predisposition to disease

KW - MHC

UR - http://www.scopus.com/inward/record.url?scp=85045958732&partnerID=8YFLogxK

U2 - 10.1038/nri.2017.143

DO - 10.1038/nri.2017.143

M3 - Review Article

VL - 18

SP - 325

EP - 339

JO - Nature Reviews Immunology

JF - Nature Reviews Immunology

SN - 1474-1733

IS - 5

ER -